Displaying drugs 4601 - 4625 of 6143 in total
Hexobarbital
A barbiturate that is effective as a hypnotic and sedative.
Experimental
Matched Salts cas: … 50-09-9 …
Inavolisib
Inavolisib (GDC-0077) is under investigation in clinical trial NCT03006172 (To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer).
Investigational
Polyhexamethyleneguanidine
Investigational
Deudomperidone
Deudomperidone is under investigation in clinical trial NCT05832151 (A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis).
Investigational
Gantenerumab
Alzheimer's disease (AD) is the most common cause of dementia in elderly patients, with classical histopathological hallmarks including extracellular amyloid-beta (Aβ) plaques and intraneuronal neurofibrillary tangles (NFTs). As the classical view of AD pathology posits that Aβ accumulation triggers tau hyperphosphorylation and aggregation to form NFTs and cause neurodegeneration, large...
Investigational
Dipropylene glycol
Experimental
HG004
Investigational
S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE
Experimental
PCLX-001
PCLX-001 is a first-in-kind N-Myristoyltransferase (NMT) inhibitor being developed by Pacylex Pharmaceuticals (https://pacylex.com). Current studies have shown that PCLX-001 works differently than other known cancer drugs and has high activity and positive results in breast, lung, bladder and pancreas cancers.
Investigational
Dihydrouridine
Investigational
Indralin
Investigational
Recombinant neuroglobin
Investigational
5-hydroxymethyl-5,6-dihydrofolic acid
Experimental
Matched Iupac: … (2S)-2-{[4-({[(6S)-2-amino-5-(hydroxymethyl)-4-oxo-3,4,5,6-tetrahydropteridin-6-yl]methyl}amino)phenyl …
4-(1,3-BENZOXAZOL-2-YL)-2,6-DIMETHYLPHENOL
Experimental
LPT-99
Investigational
Bexotegrast
Investigational
[4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE]
Experimental
Cefaloridine
Cephaloridine or cefaloridine is a first generation semisynthetic cephalosporin. It is derived from cephalosporin C and is a zwitterion at physiological pH.
Experimental
Withdrawn
Izencitinib
Izencitinib is under investigation in clinical trial NCT03920254 (TD-1473 Long-term Safety (LTS) Ulcerative Colitis (UC) Study).
Investigational
Flotegatide (18F)
Investigational
4,6-dideoxy-4-amino-beta-D-glucopyranoside
Experimental
Matched Iupac: … (2R,3R,4S,5S,6R)-5-amino-6-methyloxane-2,3,4-triol …
Zetomipzomib
Zetomipzomib is under investigation in clinical trial NCT04033926 (A Phase 2 Study of KZR-616 to Evaluate Safety and Efficacy in Patients With Active Polymyositis or Dermatomyositis).
Investigational
Displaying drugs 4601 - 4625 of 6143 in total